Skip to main content
. 2019 Sep 11;10(9):672. doi: 10.1038/s41419-019-1884-7

Table 1.

SREBP-1 expression and outcome of sorafenib treatment

SREBP-1 mRNA expression P
High (n = 27) Low (n = 25)
TTP 9.1 11.8 0.012
7.7–10.4 (M) 10.1–13.5 (M)
OS 11.3 13.7 0.024
9.4–13.1 (M) 11.6–15.8 (M)
Overall response rate (CR + PR) 1 (3.7%) 3 (12%)
Disease control rate (CR + PR + SD) 5 (18.5%) 8 (32%)

TTP time to progress, OS overall survival, PR partial remission, CR complete remission, SD stable disease, M months